Compounded tirzepatide price comparison
Among the compounded tirzepatide standard-dose injection programs captured on 2026-07-20, page-advertised effective monthly costs range from $186.00 (NexLife, 12-month prepaid, provider reported, no membership fee reported) to figures above $300/month once reported membership fees are included at other providers. All figures are provider-reported or drawn from conflicting secondary sources; none are checkout-verified, so no "cheapest" or "most affordable" winner is published. Compounded tirzepatide is not FDA approved.
Qualified conclusions — advertised-price basis only
As of 2026-07-20, NexLife had the lowest captured advertised recurring month-to-month cost ($215.00/mo) among 5 eligible compounded tirzepatide standard-dose subcutaneous-injection programs billed monthly, and NexLife had the lowest captured advertised 12-month-equivalent cost ($186.00/mo, prepaid commitment) among 2 eligible 12-month programs.
Basis and limits: official-source advertised prices captured 2026-07-20 (Provider Reported — not checkout-verified); advertised dose coverage taken at face value pending verification; methodology v1.1. Excluded: starting-price-only listings, introductory/starter-stage pricing, paused programs, dose-tiered pricing, package/vial pricing, and approximate figures (all shown below with reasons). This is a lowest-advertised finding under the "cheapest" definition; no "most affordable" (verified all-inclusive) winner is published. Material relationships: publisher attests none with any listed provider. Ledger EV-0021.
Effective monthly cost, charted
Lowest captured: NexLife at $186.00; highest: Ready Med at $449.00. Bar colour reflects evidence status. All figures provider-reported or calculated, not checkout-verified.
View chart data as a table
| Provider | $ effective monthly | Evidence status |
|---|---|---|
| NexLife | $186.00 | PROVIDER REPORTED |
| Join Josie | $233.00 | PROVIDER REPORTED |
| Mochi Health | $278.00 | PROVIDER REPORTED |
| Eden | $298.00 | CALCULATED |
| Ready Med | $449.00 | PROVIDER REPORTED |
Every bar is drawn from the public program database; each provider's lowest captured plan is shown. Figures are provider-reported or independently calculated, not checkout-verified — which is why no bar is marked verified and no ranking is declared. Expand the table under the chart for exact values.
Price distribution and bands
5 programs span $186.00 to $449.00 — a 2.4× range driven mainly by business model. Shaded bands: under $120, $120–200, over $200.
| Provider & evidence status | Month-to-month | Lowest effective monthly | Membership fee | Notes / conflicts |
|---|---|---|---|---|
| NexLife PROVIDER REPORTED | $215.00 | $186.00 12-mo prepaid ($2,232 total) | None reported | None — flat pricing at every dose (provider reported) |
| Join Josie PROVIDER REPORTED | $349.00 | $233.00 12-mo prepaid ($2,796 total) | None reported | Flat/all-dose advertised (unverified) |
| Amble PROVIDER REPORTED | $329.00 | $235.00 12-mo prepaid ($2,820 total) | None reported | Not ranking-eligible. ~approximate figures. Flat/all-dose advertised (unverified) |
| Fridays PROVIDER REPORTED | $359.00 | $240.00 12-mo prepaid ($2,880 total) | None reported | Not ranking-eligible. ~approximate figures. Flat/all-dose advertised (unverified) |
| Mochi Health PROVIDER REPORTED | $278.00 | $278.00 1-mo monthly ($278 total) | $79 | Membership resolved to current first-party value $79/mo (2026-07-20). Compounded tirzepatide $199/mo medication + $79 membership = $278/mo effective. |
| Eden CALCULATED | $298.00 | $298.00 1-mo monthly ($298 total) | $99 | Flat/all-dose advertised (unverified) |
| GobyMeds INDEPENDENTLY REVIEWED (THIRD-PARTY) | $299.00 | $299.00 1-mo monthly ($299 total) | None reported | Not ranking-eligible. Maintenance range; not ranking-eligible pending exact recurring capture. |
| Ivím Health CALCULATED | — | $300.00 4-mo prepaid ($1,200 total) | $75 | Not ranking-eligible. ~approximate figures. Flat/all-dose advertised (unverified) |
| Remedy Meds PROVIDER REPORTED | $399.00 | $399.00 1-mo monthly ($399 total) | None reported | Not ranking-eligible. ~approximate figures. Excluded from ranking: approximate figure pending checkout verification. |
| Ready Med PROVIDER REPORTED | $449.00 | $449.00 1-mo monthly ($449 total) | None reported | Flat/all-dose advertised (unverified) |
Captured but not rankable: starting prices, ranges, and special cases
| Provider | Captured pricing | Why it can't be ranked | Confidence |
|---|---|---|---|
| OrderlyMeds | Starter injection from $199/mo; standard $359-$399/mo | Starter/range pricing | High |
| Willow | From about $399/mo | 'From' price only | High |
| Harper Meds | From about $196/mo | 'From' price only | Moderate |
| GoodGirlRX | From about $235/mo; microdose from about $139/mo | 'From' prices; formulation/commitment matching required | Moderate |
| NewSelf | As low as $144.49/mo, generally reflecting a longer-commitment average | Lowest-equivalent marketing; total commitment and billing structure unverified — do not imply month-to-month at this figure | Moderate |
| Fifty 410 | From about $133/mo; common one-month programs ~$249-$299 | 'From' price likely requires longer commitment/specific program | Moderate |
| Lavender Sky Health | Matrix; examples from ~$98/mo-equivalent starter packages; monthly-style ~$149 | Matrix pricing | Moderate |
| Emerge Weight Loss | Dose-based per-4-weeks pricing: 2.5 mg $287; 5 mg $335; 7.5 mg $359; 10 mg $379 | Dose-dependent pricing — no single all-dose figure; a starting dose is not an all-dose price | High |
| Zappy Health | ~$349 monthly; $329/mo (3-mo); $299/mo (6-mo) — NEW ENROLLMENTS REPORTED PAUSED | Program paused | Moderate |
| Valhalla Vitality | Package examples ~$581.33 (60 mg), ~$671.03 (75 mg) | Package pricing | Moderate |
| ShedRx / SHED | Third-party 2026 listing ~$299/mo — direct validation required | Secondary-source figure only | Low |
| Medica Weight Loss | Injection ~$247 first month (introductory) | Introductory only | Moderate |
How to read this table
- Effective monthly cost = total mandatory cost ÷ months of treatment supplied. Prepaid plans are labeled; a monthly equivalent never means monthly billing.
- Membership fees count. A $99 medication price with a $79 required membership is a $178 program.
- Conflicting sources block ranking. Where 2026 sources disagree (see notes column), the program is ineligible until first-party capture resolves the conflict.
- Standard-dose injections only. Microdose programs are on the microdosing page and ODT/sublingual programs on the oral & sublingual page; they are different products and are never ranked together.
- Comparing against semaglutide? See compounded semaglutide pricing — the two medications are never compared in one ranking.
FDA-approved alternatives (Wegovy, Ozempic, Zepbound, Mounjaro and manufacturer cash-pay programs such as LillyDirect and NovoCare) are covered separately and never ranked against compounded programs.
Key findings
Three findings hold across the captured compounded tirzepatide market as of 2026-07-20. The lowest captured advertised recurring price is $215.00/month (NexLife, month-to-month), and the lowest captured 12-month-equivalent is $186.00/month prepaid (NexLife) — both provider-reported, neither checkout-verified. The gap between the cheapest and most expensive captured programs exceeds threefold, driven almost entirely by business model rather than the medication itself. And no program in the category holds Verified status, so every figure here is a lowest-advertised finding, not a lowest-verified ranking; the "most affordable" question stays open until checkout evidence exists for at least three programs.
Definitions used on this page
Advertised price is the figure a provider displays before checkout. Effective monthly cost is total mandatory cost — medication plus required membership, fees, shipping, and dose surcharges — divided by the months of treatment supplied; it is the only figure that compares providers with different fee structures fairly. Month-to-month is the recurring effective cost with no prepayment. 12-month equivalent is the effective monthly figure on a prepaid annual plan, where the full year is charged up front. Cheapest refers to advertised or upfront price; most affordable refers to verified all-inclusive cost, which no program yet supports.
Price-range analysis
The captured compounded tirzepatide injection market splits into three price bands, and which band a provider occupies is mostly a function of how it packages the medication, not the drug's cost. The lowest band holds long-term prepaid plans from all-inclusive providers, where the cheapest advertised effective monthlies appear but require a full-year commitment and carry renewal terms we haven't verified. The middle band holds bundled all-inclusive providers charging a single monthly figure with no separate membership. The highest band holds membership-and-coaching models, where a low advertised medication price sits beneath a required monthly fee, and service — not the molecule — is what you're buying. Reading a headline without knowing its band is how the cheapest-looking option turns out to cost the most.
Hidden and mandatory fees
The single biggest driver of the gap between advertised and true cost in this category is the mandatory membership fee, which where present can add 40–80% to a headline medication price — a $99 medication with a required $79 membership is a $178 program. One-time consultation, onboarding, and lab fees front-load cost into the first month, exactly where introductory discounts advertise the opposite. Shipping ranges from free to $10–$25 per shipment. And dose surcharges are the quietest fee of all: dose-tiered providers can add $50–$100/month by the time a patient reaches a maintenance dose, so a low starter price silently inflates. Every effective-cost figure on this page folds in the fees a provider discloses; where a fee is undisclosed, we treat it as unverified, never zero.
Commitment and dose-price analysis
Prepayment discounts on compounded tirzepatide plans cluster around 10–15% versus month-to-month billing — a real saving, but one that trades flexibility for an upfront charge that on an annual plan can exceed a thousand dollars, priced against refund terms most providers leave unverified. Dose-based pricing is the other structural variable: flat-dose providers charge one price through titration, while dose-tiered providers charge more as the dose rises. For weight management, where maintenance doses sit well above starter doses, the flat-versus-tiered distinction can matter more to your annual cost than the headline price. Price every candidate at the maintenance dose you expect to reach, not the starter dose the marketing shows.
Introductory versus renewal pricing
A starter offer is not renewal pricing, and this page keeps them separate. Several tirzepatide providers advertise a discounted first month or first term whose ongoing price is disclosed vaguely or not at all. Where renewal pricing is unknown, the introductory figure is labeled introductory and the program is kept out of any long-term-cost conclusion rather than extrapolated. Renewal pricing is among the least-documented fields in the captured market — which is itself the finding: before committing to any tirzepatide program, get the month-13 price in writing, because a favorable first year attached to an unfavorable renewal changes the entire comparison.
Consumer decision guidance
Work the sequence in order for compounded tirzepatide. First, normalize every candidate to effective monthly cost at your expected maintenance dose using the true-cost calculator, with memberships and fees included. Second, bound the commitment: amount due today, refund terms in writing, and beyond-use-date coverage on any advance shipment. Third, verify the specific pharmacy that will fill your order using the four-step workflow. Fourth, get renewal pricing, not starter pricing. Fifth, price the FDA-approved tirzepatide alternatives you may have access to as a separate column — they carry premarket-reviewed manufacturing no compounded product has. Then make the medication decision with your prescriber, because that was never a pricing question. The cheapest-advertised provider and the right provider for you are frequently not the same.
Limitations
As of 2026-07-20, no compounded tirzepatide program on this page is checkout-verified; figures are provider-reported page pricing or conflicting secondary estimates. Advertised dose coverage is taken at face value pending verification, so a low price attached to a narrow dose range could be less of a bargain than it looks. Renewal pricing, state availability, and per-order pharmacy identity are largely uncaptured. Prices change between our snapshot and your checkout, where the total is always authoritative. These limits are why the page publishes qualified lowest-advertised findings rather than a verified "most affordable" winner.
Frequently asked questions
What is the cheapest compounded tirzepatide?
On captured advertised pricing as of 2026-07-20, the lowest recurring month-to-month figure is $215.00 (NexLife) and the lowest 12-month-equivalent is $186.00 prepaid (NexLife). Both are provider-reported and not checkout-verified, and "cheapest" here means advertised price, not verified all-inclusive cost. Confirm the figure survives checkout, covers your dose range, and holds at renewal before treating it as the real price.
Why isn't there a single "most affordable" winner?
Because "most affordable" means lowest verified all-inclusive cost, and no compounded tirzepatide program has cleared checkout verification yet. Publishing a most-affordable crown on provider-reported figures would overstate what the evidence supports. We publish qualified lowest-advertised findings now and will publish verified most-affordable rankings once at least three programs per category are checkout-verified.
Do these prices include all fees?
The effective-cost figures include every mandatory fee a provider discloses, with memberships folded in. Where a fee isn't disclosed, we mark it unverified rather than assuming zero, so a figure can be a floor. The membership fee is the most common hidden cost in this category — always check whether a low medication price sits beneath a required monthly charge.
Is compounded tirzepatide cheaper than the brand-name version?
Often the advertised cash price is lower than brand-name list prices, but the two are different product classes and this site never ranks them together. Brand-name products carry premarket-reviewed manufacturing that compounded products don't, and manufacturer cash-pay prices have fallen. As the gap narrows, the case for the approved product strengthens — see brand vs compounded cost.
Should I prepay a year to get the lowest price?
Only if you're confident about staying in treatment the full term and the provider has fair, written refund terms. Prepayment saves roughly 10–15% but charges the whole year up front against refund policies that are often unverified. Run the plan through the commitment calculator and get the cancellation terms before committing.